Zachary D Reardon

  • Citations Per Year
Learn More
BACKGROUND Despite the documented survival benefit conferred by neoadjuvant (NAC) and adjuvant chemotherapy (AC), there has been a slow adoption of guideline recommendations for the use of perioperative chemotherapy (POC) in patients with muscle-invasive bladder cancer (MIBC). OBJECTIVE To evaluate temporal trends in POC utilization and identify factors(More)
  • 1